Literature DB >> 19321485

Trabecular meshwork in neovascular glaucoma eyes after the intravitreal injection of bevacizumab.

T Kubota1, R Aoki, Y Harada, N Tou, Y Kohno, A Tawara, H Satoh, S Shimajiri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19321485     DOI： 10.1136/bjo.2008.148148

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  4 in total

1.  Intravitreal bevacizumab treatment for neovascular glaucoma: histopathological analysis of trabeculectomy specimens.

Authors:  Noriko Yoshida; Toshio Hisatomi; Yasuhiro Ikeda; Ri-ichiro Kohno; Yusuke Murakami; Hiroyuki Imaki; Akifumi Ueno; Kimihiko Fujisawa; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-13       Impact factor: 3.117

2.  Effect of intravitreal bevacizumab on vascular endothelial growth factor expression in patients with proliferative diabetic retinopathy.

Authors:  Eun Jee Chung; Shin Jeong Kang; Ja Seung Koo; Yoon Jung Choi; Hans E Grossniklaus; Hyoung Jun Koh
Journal:  Yonsei Med J       Date:  2011-01       Impact factor: 2.759

3.  Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability.

Authors:  Kenichi Kimoto; Toshiaki Kubota
Journal:  J Ophthalmol       Date:  2011-11-03       Impact factor: 1.909

4.  Prognostic Factor Analysis of Intraocular Pressure with Neovascular Glaucoma.

Authors:  Satoko Nakano; Takako Nakamuro; Katsuhiko Yokoyama; Kunihiro Kiyosaki; Toshiaki Kubota
Journal:  J Ophthalmol       Date:  2016-08-14       Impact factor: 1.909
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.